Bioventus (BVS) Other Accumulated Expenses (2020 - 2026)

Bioventus (BVS) has 7 years of Other Accumulated Expenses data on file, last reported at $4.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 4.57% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (down 4.57% YoY), and the FY2025 full-year result was $4.2 million, up 7.48% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $4.2 million, down from $4.2 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $4.8 million in Q4 2023 and bottomed at $3.5 million in Q4 2022.
• The 5-year median for Other Accumulated Expenses is $4.2 million (2025), against an average of $4.2 million.
• The widest annual swing landed in 2022, when Other Accumulated Expenses plunged 61.36%; it then jumped 35.38% in 2023.
• A 5-year view of Other Accumulated Expenses shows it stood at $3.6 million in 2022, then soared by 33.52% to $4.8 million in 2023, then dropped by 18.67% to $3.9 million in 2024, then rose by 7.48% to $4.2 million in 2025, then decreased by 1.19% to $4.2 million in 2026.
• The last three Other Accumulated Expenses figures came in at $4.2 million (Q1 2026), $4.2 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.

Peer Comparison